News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Commentary|Videos|July 12, 2023

Approach to Treatment in Patients with MDD

Author(s)Greg Mattingly, MD, Jeremy Schreiber, MSN, PMHNP-BC

Practitioners discuss their approach to treatment with their patients with major depressive disorder (MDD).

Episodes in this series

EP. 1 Healthcare Perception of Major Depressive Disorder

EP. 1 Healthcare Perception of Major Depressive Disorder

EP. 2 Undertreatment in Patients Suffering From MDD

EP. 2 Undertreatment in Patients Suffering From MDD

Experts on MDD.

EP. 3 Tailoring Treatments for Patients With MDD

Experts on MDD.

EP. 4 MDD as a Chronic Condition

EP. 5 Approach to Treatment in Patients with MDD

EP. 5 Approach to Treatment in Patients with MDD

EP. 6 MDD Treatment: Follow-Up

EP. 6 MDD Treatment: Follow-Up

EP. 7 MDD Remission

EP. 7 MDD Remission

EP. 8 Treatment Switch for MDD

EP. 8 Treatment Switch for MDD

EP. 9 New Classes of Treatment for MDD

EP. 9 New Classes of Treatment for MDD

EP. 10 Practice Pearls for Optimizing MDD Treatment

EP. 10 Practice Pearls for Optimizing MDD Treatment

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

psychedelic

Phase 3 Program Investigating COMP360 Psilocybin for Treatment-Resistant Depression: Breaking Poster Data From the 2026 ASCP Annual Meeting

ByLeah Kuntz,Guy Goodwin, MD

May 28th 2026

Phase 2b/3 Trial Evaluates Forvisirvat in Major Depressive Disorder

ByJoel Raskin, MD, FRCPC

May 28th 2026

Transdiagnostic Anhedonia: A Conversation With Roger S. McIntyre, MD, FRCPC

ByJohn J. Miller, MD,Roger S. McIntyre, MD, FRCPC

May 27th 2026

Buproprion vs SSRIs: Antidepressant-Naive, Obese Patients With Major Depressive Disorder

ByFarah Khorassani, PharmD

May 27th 2026

The Significant Presence of Comorbidities in Bipolar Depression: Insights From Mark Zimmerman, MD

ByMark Zimmerman, MD

May 27th 2026

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

FDA Issues CRL for CTx-1301 for Treatment of ADHD

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

New Name, New Path for Psychiatry: The Future of the DSM

Endangered Education: Psychiatric Professional Degrees Under Attack

Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy